2024
Eosinophilia is a favorable marker for pneumonia in chronic obstructive pulmonary disease
Gu K, Jung J, Kang M, Kim D, Choi H, Cho Y, Jang S, Lee C, Oh Y, Park J, Kim J. Eosinophilia is a favorable marker for pneumonia in chronic obstructive pulmonary disease. Tuberculosis And Respiratory Diseases 2024, 87: 465-472. PMID: 38710525, PMCID: PMC11468446, DOI: 10.4046/trd.2023.0174.Peer-Reviewed Original ResearchCommunity-acquired pneumoniaChronic obstructive pulmonary diseaseCost of medical careObstructive pulmonary diseaseMedical careDuration of antibiotic treatmentReduced C-reactive protein levelsPneumonia Severity Index scorePulmonary diseaseCommunity-acquired pneumonia patientsC-reactive protein levelsHealth-care consumptionCohort study dataSeverity index scoreSeverity of pneumoniaPost hoc analysisClinical characteristicsAntibiotic treatmentFewer episodesEosinophiliaMulti-centerPatientsPneumonia patientsPneumoniaEosinophilic patients
2023
The serotype-specific prevalence of pneumococci in hospitalized pneumonia patients with COPD: a prospective, multi-center, cohort study
Kim J, Jung J, Kang M, Kim D, Choi H, Cho Y, Jang S, Lee C, Oh Y, Park J. The serotype-specific prevalence of pneumococci in hospitalized pneumonia patients with COPD: a prospective, multi-center, cohort study. The Korean Journal Of Internal Medicine 2023, 38: 714-724. PMID: 37586811, PMCID: PMC10493435, DOI: 10.3904/kjim.2023.152.Peer-Reviewed Original ResearchConceptsCommunity-acquired pneumoniaSerotype-specific prevalencePneumococcal pneumoniaCohort studyS. pneumoniaeChronic obstructive pulmonary disease patientsPneumococcal polysaccharide vaccine 23Obstructive pulmonary disease patientsPCV-13 vaccinationUrine antigen detectionPulmonary disease patientsCommon pneumococcal serotypesPost-vaccination eraPneumococcal vaccinationSerotype 22FCOPD patientsInfluenza vaccinationPCV-13Clinical characteristicsVaccination statusOverall incidencePneumonia patientsPPV-23Pneumococcal serotypesVaccination rates